SCHEMBL11158095

SCHEMBL11158095

COc1cc2c(c([S+]([O-])c3ccccc3)c1OC)CCN(C)CC2

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DRD1 P21728 6/20 0.45
▸ DRD5 P21918 4/20 0.45
▸ DRD4 P21917 2/20 0.45
▸ DRD2 P14416 5/20 0.42
▸ DRD3 P35462 3/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ CHRNA7 P36544 2/20 0.41
▸ MAOA P21397 2/20 0.40
▸ MAOB P27338 2/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ PNPLA2 Q96AD5 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ HTR7 P34969 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10709628 0.78 DRD1 (0.54) DRD1DRD5DRD4DRD2DRD3
SCHEMBL11160967 0.72 DRD1 (0.47) DRD1DRD5DRD4DRD2DRD3
SCHEMBL13928826 0.70 MAOA (0.51) DRD1DRD5DRD4DRD2DRD3
Bromide SCHEMBL11167461 0.69 MAOA (0.53) DRD1DRD5DRD4DRD2DRD3
SCHEMBL4328518 0.68 MAOA (0.62) DRD1DRD5DRD4CYP2D6LMNA
Fumaric Acid SCHEMBL11169280 0.68 MEN1 (0.43) DRD1DRD5DRD4DRD2DRD3
Fumaric Acid SCHEMBL11169294 0.68 MEN1 (0.43) DRD1DRD5DRD4DRD2DRD3
SCHEMBL10700207 0.68 DRD1 (0.51) DRD1DRD5DRD4DRD2DRD3
SCHEMBL11162262 0.67 TDP1 (0.48) DRD1DRD5DRD4DRD2DRD3
SCHEMBL11343586 0.66 MAPT (0.43) DRD1DRD5DRD4DRD2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080012-A1 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 — — EP disclosed
EP-0007070-B1 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1983-01-19 — — EP disclosed
US-4265890-A ANTIPSYCHOTIC, ANTIEMETICS SMITHKLINE CORPORATION (US) 1981-05-05 — — US disclosed
EP-0007070-A1 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity SMITHKLINE BECKMAN CORPORATION (US) 1980-01-23 — — EP disclosed
Send feedback